Dimond, Andrew
Van de Pette, Mathew
Taylor-Bateman, Victoria
Brown, Karen
Sardini, Alessandro
Whilding, Chad
Feytout, Amelie
Prinjha, Rab K.
Merkenschlager, Matthias
Fisher, Amanda G.
Funding for this research was provided by:
Wellcome Trust (PS3125_WCMA, 099276/Z/12/Z)
Medical Research Council (MC_U120027516)
Article History
Received: 15 December 2022
Accepted: 31 March 2023
First Online: 6 April 2023
Competing interests
: R.K.P. and A.F. are employees and shareholders of GlaxoSmithKline (A.F.’s involvement in this work was prior to joining GlaxoSmithKline). Twenty of the inhibitors used in this study were gifted by GlaxoSmithKline (details in Supplementary Data InternalRef removed). The authors declare no other competing interests.